In the hematopoietic system, the transcription factor GATA-3 is generally considered to be specific to the T lineage and essential for T cell differentiation from the earliest stages [1] [2] [3] . GATA-3 is used recursively throughout T cell development 4 and is a 'master regulator' of T helper type 2 differentiation 5 . When Notch-Delta signaling triggers T lineage differentiation from hematopoietic precursors, Gata3 is among the earliest regulatory genes induced 6, 7 . Thus, GATA-3 is a likely candidate for involvement near the top of a T cell-specification hierarchy. Nevertheless, several problems have complicated attempts to detect the molecular mechanisms by which GATA-3 promotes T lineage differentiation [8] [9] [10] [11] [12] . High doses of GATA factors block cell cycle progression, and GATA-3 itself can be antiproliferative in various T lineage cells unless a hypomorphic mutant is used [13] [14] [15] [16] (T.T. et al., unpublished data). However, a more radical possibility is that GATA-3 does not specifically 'instruct' cells to adopt T lineage identity, but only supports T cell development when expressed in a specific regulatory context. Here we have revisited the issue by seeking to determine more broadly what 'instructive' effects GATA-3 may have on developing prethymic and intrathymic lymphoid precursors when viability problems are circumvented. We assessed both Notch-dependent and Notch-independent functions of GATA-3 using the continuous monitoring available in the monolayer culture system of OP9 stromal cells (OP9-control) and OP9 cells transfected with the Delta-class Notch ligand Delta-like 1 (OP9-DL1) 17 .
Our results show that GATA-3 does not necessarily confer T lineage identity but can efficiently divert T lineage precursors to an alternative, coherent developmental program. The early T lineage function of GATA-3 is thus profoundly dependent on context and dose. Overexpressed GATA-3 was antagonistic, not synergistic, with Notch-Delta signaling for the survival of pro-T cells. Yet more GATA-3 conferred the gain of a different function, rapidly and efficiently promoting mast cell differentiation. This mast cell lineage response was available to a large fraction of thymocytes during stages before the c-Kit lo CD44 lo CD25 + (double-negative 3 (DN3)) stage. In those stages, the cells also retain some natural killer cell, dendritic cell and macrophage developmental potential [18] [19] [20] [21] [22] , but we show here that the diverted thymocytes took a direct route toward mast cell differentiation that was distinct from any of those developmental pathways. Furthermore, pro-T cells with unmanipulated GATA-3 expression also accessed the mast cell-differentiation pathway, albeit at a lower frequency. Our results elucidate a previously unknown aspect of the T lineage-commitment process and show an unexpectedly intimate link between the T cell and mast cell developmental programs.
RESULTS

GATA-3 blocks the initiation of T cell development
As Gata3 is one of the earliest T cell-specific genes induced by Notch-DL1 stimulation of fetal liver hematopoietic precursor cells 6, 7 , we initially tested whether GATA-3 is the principal effector of T lineage differentiation activated by Notch, or whether GATA-3 promotes T cell development only in synergy with continuing Notch-Delta signals. In either case, the kinetics of GATA-3 induction could be ratelimiting for the initiation of T cell development, and exogenous GATA-3 might either bypass the requirement for Notch signaling or accelerate the response to it. Despite possible antiproliferative effects, we expected to be able to detect any T lineage-inducing activity by transducing GATA-3 into purified hematopoietic precursors and through use of the OP9 culture system to track the early time course of their differentiation in the presence or absence of DL1.
A T lineage-promoting activity of GATA-3 might be found in stem cells, accelerating them toward a lymphoid-restricted progenitor state, or in cells that are already lymphoid restricted. Therefore, we tested purified fetal liver cell samples enriched for lymphoid progenitor cells (c-Kit + Sca-1 -Lin -CD27 + CD135 + CD127 + ; called 'LEP cells' here) as well as more primitive hematopoietic precursor cells (Lin -Sca-1 + Kit + ; called 'LSK cells' here; Fig. 1a ). Both populations generated CD19 + cells of the B lineage on OP9-control stroma and cells of the T lineage on OP9-DL1 stroma, progressing from the CD44 + CD25 -(DN1) stage to the CD44 + CD25 + (DN2) and CD44 -CD25 + (DN3) DN3 stages within about 7 d (Fig. 1b) . As expected, the LEP cells reached these lymphoid benchmarks more rapidly than the LSK cells did (Fig. 1b) .
However, when we introduced GATA-3 by means of a bicistronic retroviral vector, we found that neither prethymic precursor population showed enhanced early T lineage differentiation after transduction with GATA-3 relative to that of cells transduced with empty vector control (LZRS), using vector-encoded expression of enhanced green fluorescent protein (EGFP) to distinguish retrovirustransduced cells from untransduced cells. Transduction of GATA-3 reduced cell yield on both OP9-control and OP9-DL1 stroma (Fig. 1c) and blocked the appearance of Thy-1 + CD25 + cells. We present data here for precursor cells transgenic for expression of the antiapoptosis protein Bcl-2, which gave better cell recovery, but wild-type cells yielded similar results ( Supplementary Fig. 1 online) . In the absence of Notch-DL1, GATA-3 was not sufficient to promote entry into the T cell pathway (Fig. 1c, left) , although the substantial cell loss indicated it efficiently blocked B cell development (T.T., A. Arias, unpublished data). Moreover, even with appropriate Notch stimulation (OP9-DL1), GATA-3 did not accelerate T lineage differentiation; instead, it inhibited T lineage differentiation from both progenitor subsets. The CD44 and CD25 profiles of surviving GATA-3-transduced cells demonstrated retarded development and reduced cell yields relative to those of LZRS-transduced cells. Therefore, in prethymic precursors, artificially high GATA-3 was neither sufficient nor permissive for initiation of the T lineage even in 'collaboration' with Notch signaling.
GATA-3 promotes thymocyte survival without Notch-DL1 Thymus entry and the initiation of T cell differentiation do not protect cells from the T lineage-inhibitory effects of GATA-3 overexpression, as GATA-3-transduced fetal thymocytes were also inhibited in T lineage differentiation on OP9-DL1 stroma (Fig. 2a) , confirming results from other assays 9, 11 . Although most cells remained Thy-1 + , the yield of GATA-3-transduced cells and differentiation to the CD4 + CD8 + double-positive stage were much lower than those of LZRS-transduced control cells (Fig. 2a) . GATA-3-transduced fetal thymocytes accumulated as DN1-and DN2-like cells with less CD25 expression than normal DN2 cells (Fig. 2a) . We noted similar developmental effects with Bcl-2-transgenic thymocytes, with less effect on viable cell yield ( Supplementary Fig. 2 online) .
However, intrathymic precursors showed a positive response to GATA-3 overexpression. Transduction of GATA-3 enhanced the proliferation and survival of thymocytes when Notch-DL1 signaling was absent. This result contrasts with those obtained with unmanipulated DN1-DN3 thymocytes, which require continuous NotchDelta interaction 7, 20 . GATA-3-transduced thymocytes consistently underwent less population expansion than control LZRS-transduced cells on OP9-DL1 stroma but substantially more than LZRStransduced cells on OP9-control stroma (Fig. 2a,b) . Furthermore, the cells increased in size and included a subset with very high c-Kit expression (Fig. 2c) . These c-Kit hi cells did not express myeloid markers and differed from normal c-Kit + thymocytes, lacking not only Thy-1 but also CD27 (Fig. 2c) , a marker normally expressed together with c-Kit on intrathymic progenitors 7,23-25 . The c-Kit hi CD27 -cells were also among the survivors of GATA-3-transduced fetal liver cell populations (not shown), but the survival advantage of GATA-3-transduced thymocytes in the absence of DL1 contrasted with the poor survival of GATA-3-transduced fetal liver precursors in the same conditions. T lineage priming or B lineage inhibition by Notch-Delta signaling could underlie the difference (Fig. 2d) , as a 5-day preculture of c-Kit + CD27 + Lin -fetal liver precursors in 'T lineage conditions' (OP9-DL1), before transduction of LZRS or GATA-3, generated a population that responded to GATA-3 similarly to freshly isolated fetal thymocytes (Fig. 2a,d ). When these cells were returned to T lineage conditions (OP9-DL1) after transduction, GATA-3 overexpression again reduced the frequency of EGFP + cells and blocked T cell development. However, the frequency of GATA-3-transduced cells increased and c-Kit + CD27 -cells were generated when these cells were switched to cultures in the absence of Notch signaling after transduction (Fig. 2d) .
The ability of GATA-3 to inhibit growth in the presence of DL1 and to promote the growth of c-Kit hi CD27 -cells in the absence of DL1 was similar to the effects of the known essential mast cell factor GATA-2 (refs. [26] [27] [28] when it is ectopically expressed in thymocytes (Supplementary Fig. 2) . However, the emergence of c-Kit hi cells did not depend directly on T lineage inhibition, as the two effects could be separated. The hypomorphic KRR mutant of 16, 29) was much less inhibitory of T cell development on OP9-DL1 stroma than was wild-type GATA-3 or GATA-2 ( Supplementary Fig. 2 and data not shown). However, it was equally effective in generating c-Kit hi CD27 -Thy-1 -cells from thymocytes in the absence of DL1 ( Supplementary Fig. 2) . Furthermore, the KRR mutant induced this developmental change through gene-expression effects closely matching those of wild-type GATA-3, described below (Supplementary Fig. 3 online) .
GATA-3 redirects thymocytes to the mast cell lineage
We further characterized the unusual c-Kit hi population generated by GATA-3-transduced thymocytes. To confirm that c-Kit hi cells can be derived from cells that have already initiated T cell differentiation (Thy-1 + ), we transduced C57BL/6 fetal thymocytes overnight with LZRS ( Fig. 3a) or GATA-3 ( Fig. 3b) and then sorted Thy-1 + EGFP + and Thy-1 -EGFP + cells and placed them in OP9-control culture. After 5 d, we resorted the cultured samples to separate various stages of response to GATA-3 based on expression of Thy-1 and c-Kit (Fig. 3a,b , right). Transduction of GATA-3 caused c-Kit hi cells to emerge from both Thy-1 + precursors (Fig. 3b , populations D and E) and Thy-1 -precursors (Fig. 3b , population G). To test whether those c-Kit hi cells corresponded to stem or multipotent progenitor cells, mast cells or other hematopoietic cells, we tested the sorted populations (Fig. 3a,b , populations A-G) by colony-forming assay ( Table 1) , in mast cell culture conditions ( Table 1 and Fig. 3c -e) and by geneexpression analysis (described below).
GATA-3-transduced thymocytes acquired de novo the ability to form colonies in methylcellulose ( Table 1 ) and to proliferate extensively in mast cell culture conditions including interleukin 3 (IL-3) and stem cell factor (SCF; Table 1 ). These new growth properties were acquired whether cells were originally Thy-1 -or Thy-1 + (DN2 stage or later) at transduction, but were confined to those cells that had upregulated c-Kit by day 5 in response to GATA-3 ( Table 1, form colonies or grow detectably in mast cell culture, and a distinct GATA-3-transduced Thy-1 + c-Kit -subset ( Table 1 , population C) also did not grow in these conditions. The c-Kit + GATA-3-transduced cells grown for approximately 2 weeks in mast cell culture conditions resembled large and granular c-Kit + FceRIa + bone marrow-derived mast cells (BMMCs) both morphologically and phenotypically ( Fig. 3c-e) , distinct from normal thymocytes (Fig. 3f) .
Pathway for thymocyte respecification by GATA-3 Mast cell-lineage respecification by GATA-3 began immediately after transduction with GATA-3 ( Fig. 4a,b) . Upregulation of c-Kit began within 1 d after transduction with and without Notch-DL1 signaling (Fig. 4a) , whereas most control cells transduced with empty vector lost expression of c-Kit while retaining expression of CD27, consistent with T lineage identity. Distinct c-Kit hi CD27 lo Thy-1 lo cells emerged from GATA-3-transduced cultures by day 3 with or without Notch-DL1 signaling but emerged more efficiently in its absence (Fig. 4a) . Further expansion of this c-Kit hi CD27 lo population depended on the absence of DL1.
In addition to upregulating c-Kit, GATA-3 upregulated the expression of a full battery of mast cell-specification genes within the first day. Such expression occurred without cell death in Bcl-2-transgenic thymocytes and whether or not Notch signals were present (Fig. 4b) . After transduction and 1 day of culture on OP9-control or OP9-DL1 stroma, exogenous GATA-3 increased total Gata3 RNA by about 30-fold and resulted in rapid upregulation of Gata1 and Gata2 (Fig. 4b) . Notably, however, endogenous Gata3 was not upregulated by GATA-3 (discussed below). In addition to Gata2 and Gata1, two other genes encoding transcription factors required by mast cells, Mitf and Tal1 (encoding SCL), were also upregulated by GATA-3, as was the mast cell effector gene Cpa3. At the same time, pro-T cell genes encoding transcription factors (Tcf7 and Lef1) and effector molecules (Il7ra and Rag1) were downregulated. These changes did not reflect dedifferentiation or reversion toward a common myeloid precursor state, as Sfpi1, encoding a key determinant of myeloid potential in DN1 and DN2 pro-T cells (PU.1), was initially downregulated by GATA-3 rather than being upregulated (Fig. 4b) . These early effects on T cell gene expression were very selective. Many pro-T cell genes were relatively unaffected by GATA-3 overexpression at this time point in the presence or absence of DL1 ( Fig. 4b and Supplementary Fig. 3 ). These included Cd3e, Cd3g, Lat and genes encoding the transcription factors c-Myb, Ets, Ikaros, Gfi1 and bHLH E-proteins, all of which are rapidly downregulated when thymocytes are diverted to the myeloid or dendritic cell pathways 30 .
Notch-DL1 signals moderated the effects of GATA-3 on many of its targets (Fig. 4b) . Several pro-T cell genes require continuous Notch signals to maintain their expression, but in most cases there was no evidence of interaction between GATA-3 and the Notch effects ( Supplementary Figs. 3 and 4 online) . Notch1, Notch3 and the Notch targets Deltex1 and Nrarp, as well as pro-T cell genes (Ptcra in particular), required continuing Notch-Delta signaling for expression, with few or no GATA-3 effects in either condition (Fig. 4b and Supplementary Figs. 3 and 4) . However, the Notch target gene Hes1 was upregulated by GATA-3 and was fully protected by GATA-3 from downregulation when Notch signals were withdrawn ( Fig. 4b and Supplementary Fig. 3 ).
The upregulation of mast cell-associated genes by GATA-3 seemed to be independent of mast cell cytokine signaling, as it occurred rapidly in the absence of exogenous IL-3 and was unaffected by the addition of SCF ( Supplementary Fig. 4) . The immediate onset of these effects indicated that GATA-3 itself was responsible, rather than the GATA-2 it induced, as absolute amounts of GATA-2 at this time point remained relatively low ( Supplementary Fig. 3 ). Thus, it seems that GATA-3 overexpression can directly and rapidly impose a new regulatory program in developing thymocytes.
Establishment of a mast cell gene-expression program
The initial changes in gene expression after 1 d in culture progressively intensified over the next 4 d in OP9-control cultures, specifically for cells that went on to have high expression of c-Kit. We measured the gene expression of cell populations obtained from 5-day OP9-control cultures by quantitative RT-PCR and found specific differences between those GATA-3-transduced cells that were able to divert to the mast cell lineage (Fig. 4c, D and E) and those unable to divert despite GATA-3 transduction (Fig. 4c, C) , or LZRS-transduced control cells (Fig. 4c, A and B; populations, Fig. 3 ). We also compared the effects on day 5 with gene-expression changes in GATA-3-transduced cells after a further 2 weeks of culture in Methocult or with the mast cell cytokines IL-3 and SCF (Fig. 4c) , with which the cells fully converted to mast cell phenotype (Fig. 3c-e) . Because of the large dynamic range of effects, we present these results as absolute gene expression obtained for these samples relative to expression of the gene encoding b-actin, with gene expression in normal fetal liver and fetal thymocytes at embryonic day 14.5 (E14.5) and BMMCs presented for reference (Fig. 4c) .
By day 5, Gata1, Gata2, Mitf, Tal1 and Cpa3 were all upregulated in the c-Kit hi Thy-1 -subset to expression approaching or matching that of BMMCs (Fig. 4c) . The expression of another mast cell-specific gene encoding the effector tryptase (Mcpt6), which was not upregulated at day 1 ( Supplementary Fig. 3 ), also increased considerably by this time. Mast cell specification depends on a 'collaborative' interaction between GATA factors and moderate amounts of PU.1 (ref. 27) , and despite the initial drop in PU.1 expression, c-Kit + GATA-3-transduced cells stabilized PU.1 expression similar to or approaching that of BMMCs at this time point (Fig. 4c) . The c-Kit + GATA-3-transduced cells also matched mast cells, rather than myeloid or erythro-megakaryocytic cells, in their low expression of genes encoding the transcription factor C/EBP-a (Cebpa), hemoglobin-b (Hbb-b1), the thrombopoietin receptor (Mpl) and the erythropoietin receptor (Epor) and in their expression of regulatory genes such as Fog1, Fli1, c-Myb, Ets2, Runx3 and Gfi1 ( Supplementary Fig. 5  online) . Thus, these changes quantitatively established a mast cell-like program within 5 days in lymphoid culture conditions (Fig. 4c) . There was little further increase in mast cell gene expression in GATA-3-transduced cells grown in long-term IL-3-SCF culture (Fig. 4c) .
GATA-3-transduced cells with mast cell lineage potential (Fig. 3b , populations D and E, and long-term cultures) now lost expression of diverse pro-T cell genes in a pattern reciprocal to that of mast cell gene activation; this included not only Tcf7 and Lef1 but also Lck, Zap70 and others, approaching the phenotype of BMMCs. Furthermore, many Notch-dependent genes, including Ptcra, Rag1, Deltex1 and Notch1 itself, were downregulated by culture on OP9-control stroma because of loss of Notch signals (Fig. 4c and Supplementary  Fig. 5 ). However, GATA-3-transduced cells maintained moderate expression of Notch1 as well as of the Notch-responsive gene Hes1, even after 5 d of absence of Notch-DL1 signaling, in amounts similar to that of BMMCs. Notably, among pro-T cell genes, only Cd3e expression was maintained in all GATA-3-transduced cells derived from Thy-1 + cells (Fig. 4c) , in contrast to its complete absence from BMMCs. This stable Cd3e expression distinguished thymocyte-derived mast cells from normal BMMCs and confirmed their T lineage origin. 
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Expression (log Supplementary Fig. 4) . (c) Gene-expression analysis of thymocytes (populations A-E from Fig. 3a,b) undergoing or resisting diversion, assessed 5 d after transduction. LZRStransduced Thy-1 + cells (LZT + ) and Thy-1 -cells (LZT -; populations A,B) are compared with distinct subsets of GATA-3-transduced Thy-1 + cells (G3T + ; populations C-E) and GATA-3-transduced Thy-1 + cells grown in mast cell culture (MC culture; IL-3 and SCF) or in Methocult (colonies; colony-forming assay). T, Thy-1; K, Kit; gray boxes outline GATA-3-diverted samples. Data are geometric means of two independent experiments presented on a log scale in units relative to b-actin (error bars, one s.d.). Although all GATA-3-transduced cells had similar amounts of GATA-3 mRNA, about ten times more than that of normal thymocytes (Fig. 4c) , the effect of GATA-3 on other genes correlated with the ability or inability of each population to generate mast cells ( Table 1) . (1) and (2) in key).
gene-expression profiles for c-Kit + Thy-1 + cells (Fig. 4c) . These results suggested variations in cell responses to overexpression of GATA-3 (discussed below).
Thus, the subpopulations of GATA-3-transduced Thy-1 + fetal thymocytes that were able to generate mast cells had already switched within 5 d to a gene-expression profile comprehensively matching that of BMMCs rather than that of pro-T cells. Positive upregulation of mast cell genes encoding transcription factors is among the earliest responses to GATA-3, providing regulatory partners that can cooperate to enforce the lineage switch. These changes in programming were driven by overexpression of GATA-3 before any selection in IL-3 and SCF ( Supplementary Fig. 6 online) .
Developmental window and frequency of lineage shift
To determine whether initial developmental stage differences were underlying those distinct responses to GATA-3, we purified E14.5 C57BL/6 DN1, DN2 and DN3 fetal thymocytes and compared their responses to transduction of GATA-3 or LZRS (Fig. 5) . Transduction of GATA-3 promoted the development of Thy-1 lo c-Kit + cells (Fig. 5b) from both DN1 and DN2 starting populations. Both yields and c-Kit intensities were much higher for transduced cells cultured on OP9-control stroma than for those cultured on OP9-DL1 stroma. The phenotype of EGFP + GATA-3-transduced cells diverged from that of the EGFP -cells in the same samples, which remained overwhelmingly Thy-1 + and progressed normally to c-Kit -cells (EGFP -).
In contrast to DN1 and DN2 cells, DN3 cells failed to upregulate c-Kit after GATA-3 transduction and responded with only partial downregulation of Thy-1 on OP9-control stroma. Both c-Kit upregulation in DN1 and DN2 cells and Thy-1 downregulation in DN2 and DN3 cells were specific effects of GATA-3 transduction (Fig. 5a-d) . When we cultured sorted EGFP + cells from the OP9-control and OP9-DL1 cultures with IL-3 and SCF, mast cells developed and grew progressively from the DN1 and DN2 cells transduced with GATA-3, whereas DN3 cells had apparently lost the ability to undergo this fate conversion (Fig. 5a,b) . Thus, a developmental constraint imposed between the DN2 and DN3 stages sets the boundary for competence to 'transdifferentiate' in response to GATA-3. We have summarized this developmental boundary, the changes in gene expression that may contribute to it and their relationship to Notch signaling effects ( Supplementary Fig. 6 ).
The ability to be diverted by GATA-3 was common in the DN2 thymocyte population, as shown by precursor frequency analysis (Fig. 5e) . Optimal conditions for mast cell conversion yielded precursor frequencies of 1/15 to 1/25 for GATA-3-transduced C57BL/6 DN2 thymocytes (Fig. 5e) . However, as lineage conversion entails a poorly characterized switch in survival requirements, we also tested Bcl-2-transgenic DN2 cells, which showed substantially increased precursor frequencies of 1/2 to 1/3 when transduced with GATA-3 (Fig. 5e) . Thus, when interim survival is not an issue, GATA-3 is highly efficient in redirecting T cell precursors to the mast cell lineage. Furthermore, untransduced Bcl-2-transgenic DN2 cells showed low but detectable mast cell development (Fig. 5e) .
Mast cell potential of unmanipulated thymocytes
The unexpected diversion by GATA-3 of T cell progenitors to mast cell development and the low frequency of mast cell development from Bcl-2-transgenic DN2 cells urged us to investigate the mast cell lineage potential of normal, unmanipulated thymocytes. Although they are known to be uncommitted, early T cell precursors have not been shown to have mast cell potential. We sorted the most immature fetal thymocytes, separating c-Kit + Thy-1 -CD25 -(pre-DN1 and DN1-like) and c-Kit + Thy-1 + CD25 + DN2 thymocytes (Fig. 6a) . Both demonstrated the ability to generate CD4 + CD8 + T lineage cells, with different kinetics as expected corresponding to their initial developmental stage (Fig. 6b and data not shown) . In the presence of Notch-DL1 signaling, no FceRI + c-Kit + cells developed, even with exogenous SCF and IL-3. However, on OP9-control stroma with exogenous SCF plus IL-3 as well as IL-7, mast cells emerged within 3-4 weeks. The c-Kit + Thy-1 + CD25 + DN2 thymocytes were able to generate mast cells, as demonstrated by phenotype (Fig. 6c) and morphology (Fig. 6d,e) , and they showed this response even when the more primitive c-Kit + Thy-1 -CD25 -thymocytes were unable to do so. Thus, even some normal fetal thymocytes have mast cell lineage potential that is repressed by Notch1-DL1 signaling. Furthermore, this potential is most accessible in T cell precursors that have already initiated T lineage specification, suggesting a close relationship between the initial developmental stages of both lineages. DISCUSSION GATA-3 is activated in response to Notch-Delta signaling as an early and essential event in T lineage specification. We have shown here that GATA-3, when highly expressed, diverted thymocytes from the T lymphoid pathway by activating a mast cell-like program independently of the exogenous mast cell growth factors IL-3 and SCF. Diversion occurred at the same stages of pro-T cell development as those when GATA-3 is normally required for the DN1-to-DN2 transition and was highly efficient, especially for DN2 thymocytes. Thus, the positive functions of GATA-3 for T lineage development are intrinsically dose dependent. Abundant GATA-3 immediately activated mast cell regulatory and differentiation genes in pro-T cells and 'handicapped' viability in the presence of Notch-Delta signaling but actively promoted survival and proliferation when the Notch ligand DL1 was removed. Notch signals seemed to moderate GATA-3 effects in part by blunting changes in gene expression and sustaining expression of T cell genes, but also by blocking the growth of cells overexpressing GATA-3. Consistent with that finding, some normal, unmanipulated DN2 thymocytes also showed mast cell lineage potential, but only in the absence of Notch-DL1 signaling and in the presence of mast cell-supporting cytokines.
In vivo relationships between T lineage cells and mast cells have been suggested for a long time 31 but without evidence of a definite pathway. The notable ability of mast cells to express a broad range of 'T lineagespecific' cytokines as well as GATA-3 indicates some convergence of T cell and mast cell 'programming' . The T cell marker Thy-1 identifies mast cell precursors in fetal blood, as Thy-1 lo c-Kit hi cells show mast cell potential, in contrast to their Thy-1 -c-Kit + counterparts 32 . The thymus has been identified as a site of mast cell development in chicken embryos 33 . Mast cells have also been reported in human thymuses in pathological cases 34, 35 and are found in medullary regions, which are poor in Delta-class Notch ligands 36, 37 . Our results suggest that such mast cells could develop intrathymically, possibly amplified in situ by a breakdown of Notch-dependent restraints.
The main regulatory pathway for normal mast cell differentiation is not well characterized. Balanced activity of PU.1 and GATA factors is known to be required, along with the transcription factors Mitf and possibly SCL, and the functions of GATA-2 and GATA-1 in this process can now be distinguished 27, [38] [39] [40] . However, it has remained obscure whether mast cells are 'myeloid' or are in a distinct class of their own. They can be derived from precursors separate from most myeloid lineages 38, 41 . Unlike monocyte and granulocyte lineages, but corresponding to lymphocytes, they develop through a pathway that excludes C/EBP-a 42 . Thus, our results have provided concrete evidence for one specific function, increased GATA-2 or GATA-3 expression, that provides direct access to the mast cell pathway for an uncommitted but differentiating lymphoid precursor. We do not propose that the thymus is the chief source of mast cells, but early developing T cells seem to be primed for mast cell development and may provide an excellent model system for delineating the distinct regulatory stages of mast cell lineage commitment.
The diversion of immature thymocytes to the mast cell lineage is triggered by GATA-3, a factor these cells express normally. High GATA-3 expression may affect target genes that can be regulated by GATA-2 in prethymic precursors, as both have similar effects. However, our results have shown that differences in absolute expression were all that was needed to distinguish between the contributions of GATA-3 to the T cell lineage and GATA-3-driven diversion to the mast cell lineage. The ability of some DN2 cells with barely detectable expression of GATA-2 to differentiate into mast cells without exogenous GATA-3 suggests that their endogenous GATA-3 expression can extend into the mast cell-supporting range.
The mast cell program seems to be accessible only to thymocytes at the DN1 and DN2 stages, which also preserve latent natural killer cell and dendritic cell or even macrophage developmental potential. This finding raises the issue of whether lineage plasticity depends on initial retrogression to some common myeloid-lymphoid precursor state before the adoption of any of these alternative fates. If so, then the mast cell 'reprogramming' would be an example of such general lymphomyeloid plasticity 43 . For mast cell versus monocyte or dendritic cell alternatives, however, this possibility can be excluded. Diversion of pro-T cells to these different pathways can be triggered synchronously by an increase in GATA-3 or PU.1, respectively, making it possible to compare the programs of regulatory change. The time courses of effects on gene expression 30 show that the two paths are completely distinct.
For PU.1-mediated monocytic-dendritic respecification, most early effects tend broadly to inhibit pro-T cell gene expression, including genes encoding signaling kinases and the transcription factors c-Myb, HES-1 and Gfi1, bHLH factors and Ets factors as well as TCF-1; Gata3 is not affected much 30 . In this context, PU.1 upregulates its own expression, along with weak upregulation of the transcriptional inhibitor Id2 and a few myeloid genes that are induced much more strongly later 30 . In contrast, the dominant GATA-3 effect was the immediate upregulation of mast cell-associated genes, including Gata2, long before most T lineage genes were downregulated. GATA-3 upregulation had no effect whatsoever on Myb, Gfi1, Ets1 or Ets2 and acts as a positive regulator of Hes1 while transiently downregulating PU.1. The early upsurge in expression of GATA-2, Mitf and GATA-1 provides regulatory partners that may assist or replace GATA-3 for the expression of later mast cell gene products, such as tryptase. Thus, GATA-3 immediately redirects immature thymocytes to a mast cell state without 'crossing paths' with the monocyte-dendritic programs controlled by PU.1 and/or C/EBPa 30, 44 . In fact, the transient repression of PU.1 in GATA-3-transduced DN1 and DN2 cells may be important for blocking access to the monocyte or dendritic alternatives until the new regulatory state is established. Thus, the mast cell pathway, accessible to a few DN2 thymocytes naturally and to a large fraction of them when GATA-3 is increased, represents a qualitatively distinct, additional option for pro-T cells.
Notch-Delta signaling restrains the access of pro-T cells to the mastcell pathway. We have shown here that Notch-Delta signaling enforced a 'survival penalty' on pro-T cells overexpressing GATA-3 that was only partially counteracted by Bcl-2 expression. With lower, endogenous expression abundance of GATA-3, in contrast, Notch and GATA-3 were jointly required for the viability of pro-T cells (D.D. Scripture-Adams and E.V.R., unpublished data). Notch-Delta signaling also blunted but did not prevent the upregulation of mast cell genes by abundant GATA-3 expression. These antagonistic Notch effects on high GATA-3 activity were not mediated by HES-1 (ref. 45) , as GATA-3 upregulates Hes1 independently of Notch. HES-1 can promote precursor population expansion 46 , and it is possible that the selective upregulation of Hes1 by GATA-3 contributes to its ability to enhance cell growth in the absence of Notch signaling. Other Notch-induced mediators must be responsible for 'penalizing' cells overexpressing GATA-3.
If a substantial increase in GATA-3 can reveal the mast cell potential of DN1 and DN2 thymocytes, then the mechanisms normally restricting GATA-3 abundance in vivo must be robust to keep this potential obscured. However, each of the hematopoietic GATA genes has positive autoregulation potential, including that encoding GATA-3 itself in peripheral T cells [47] [48] [49] , and presumably GATA-3 activated GATA-1 and GATA-2 in our studies by acting through their autoregulatory target sites. In pro-T cells, then, GATA-3 itself must be prevented from positive autoregulation; our gene-expression analysis supported this idea. The positive functions of GATA-3 in T lineage differentiation may therefore depend paradoxically on damping functions that prevent autoactivation and thus maintain the uniquely balanced regulatory state of T lineage precursors.
T lineage commitment at the DN3 stage coincides with an increase in GATA-3 RNA expression 22 , as GATA-3 is required for b-selection 50 , whereas the cells lose sensitivity to the mast cell-diversion activity of GATA-3. The 'window' for susceptibility to diversion probably depends on specific gene-regulatory features of DN1 and DN2 fetal thymocytes, such as the persistence of PU.1 or SCL. In any case, our results here suggest that diversion depends on the ability of GATA-3 to rapidly upregulate Gata2, Tal1 and Mitf. The T lineage-commitment process may therefore result from increasing restrictions on the accessibility of genes such as those to activation, or reactivation, during a stage when high GATA-3 activity becomes vital for a new, T cell receptor-dependent function.
METHODS
Monoclonal antibodies and flow cytometry. The monoclonal antibodies have been described 7, 23 , except for the following (all from eBioscience): antibody to CD19 (anti-CD19; 6D5; conjugated to phycoerythrin and phycoerythrinindodicarbocyanine), anti-CD127 (A7R34; conjugated to phycoerythrinindodicarbocyanine), anti-CD135 (A2F10; conjugated to phycoerythrin), anti-FceRIa (MAR-1; conjugated to phycoerythrin) and anti-Sca-1 (D7; conjugated to fluorescein isothiocyanate). For detection of biotinylated antibodies, streptavidin-Alexa Fluor 405 (Invitrogen) was used. Cells were stained after blockade of Fc receptors as described 7, 23 . Cells were sorted on a FACSVantage SE or FACSAria and were analyzed on a FACSCalibur (Becton Dickinson Immunocytometry Systems). Data were acquired and analyzed with CellQuest Pro or Diva software (Becton Dickinson Immunocytometry Systems) or FlowJo software (TreeStar). All fluorescence data are plotted on a 'four-decade' logarithmic scale with forward scatter and cell numbers on a linear scale.
Fetal tissues. C57BL/6, (C57BL/6 Â DBA/2)F 1 (BDF1) and Em-Bcl-2-25 (Bcl-2-transgenic) mice at E14-E14.5 were generated from our colony 30 or were obtained from the Caltech Genetically Engineered Mouse facility. Fetal liver cell samples were depleted of cells positive for lineage markers as described 7, 23 . Fetal thymus tissue was mechanically disrupted with a Dounce homogenizer and the resulting cell suspensions were filtered before staining. All animal protocols were reviewed and approved by the Institute Animal Care and Use Committee of the California Institute of Technology.
Retroviral gene transfer. GATA-3 and the KRR mutant of GATA-3 were inserted into the bicistronic LZRS retroviral vector containing an internal ribosomal entry site-EGFP cassette and were packaged with the Phoenix-Eco packaging cell line as described 15 . Viral supernatants were collected and were stored in aliquots at -70 1C until use. Transduction conditions were essentially as described 7, 23 . Non-tissue culture plates (24-or 96-well; Corning) were coated for 2 h at 20-25 1C with retronectin (24 mg/ml), then were blocked for 30 min with 2% (wt/vol) BSA in PBS and were incubated for 4 h at 37 1C with retroviral supernatant. After coating, viral supernatant was removed and cells were added immediately in OP9 coculture medium as described 7, 23 , always with the receptor tyrosine kinase ligand Flt3L (5 ng/ml) and IL-7 (5 ng/ml). Cells were then cultured on the virus-coated plates overnight (15-20 h) for transduction.
Cell culture conditions. Conditions for OP9-DL1 and OP9-control stromal cocultures have been described 7, 23 . All cytokines were from Peprotech and all tissue culture media were from Invitrogen except where indicated otherwise. Differentiation cultures contained 5 ng/ml each of Flt3L and IL-7, except for specific OP9 cocultures, in which Flt3L was replaced by SCF (5 ng/ml) where indicated. In some experiments, substitution of SCF for Flt3L enhanced the detection of c-Kit + cells over a 5-day period, but this seemed to reflect enhanced survival, as it had no detectable effect on the initial changes in gene expression induced by GATA-3 ( Fig. 4 and Supplementary Fig. 4) . Several different culture conditions were used for the generation of mast cells from pro-T cells. In experiments with sorted DN subsets (Fig. 5a-d) , after OP9 culture, EGFP + sorted cells were cultured in IL-3 (50 ng/ml) and SCF (20 ng/ ml). For limiting-dilution analysis (Fig. 5e) , transduced or mock-transduced DN2 cells were sorted directly onto OP9-control cells with IL-7 (5 ng/ml) plus IL-3 (50 ng/ml) and SCF (20 ng/ml). Medium plus IL-3 and SCF, but not IL-7, was replaced after 1 week. For the generation of mast cells from normal thymocytes, cocultures contained IL-7 (5 ng/ml) and Flt3L (5 ng/ml) or contained SCF (20 ng/ml) and IL-3 (50 ng/ml) along with IL-7 (5 ng/ml) and Flt3L (5 ng/ml). In this case, IL-7 and Flt3L were omitted from the cultures after 2 weeks. Methocult GF M3434 (StemCell Technologies), containing SCF, IL-3, IL-6 and erythropoietin, was used for colony-forming assays according to the instructions of the manufacturer, with 10 Â 10 3 to 25 Â 10 3 sorted transduced fetal thymocytes or 100 Â 10 3 to 250 Â 10 3 bone marrow cells. Colonies were counted after 9-14 d of culture. Cells were collected for RNA analysis by vigorous pipetting of the semisolid cultures with 10 ml unsupplemented DMEM medium followed by centrifugation. For mast cell culture from Thy-1-and c-Kit-sorted cells (Fig. 3 and Table 1 ), after 5 d of culture together with OP9-control cells plus IL-7 and Flt3L, 10 Â 10 3 to 100 Â 10 3 sorted transduced fetal thymocytes or 1 Â 10 5 bone marrow cells were placed in DMEM supplemented with 10% (vol/vol) FBS, penicillin, streptomycin and L-glutamine, mixed 9:1 with medium conditioned by WEHI-3B cells (American Type Culture Collection) as a source of IL-3, plus SCF (5 ng/ml). Medium and cytokines were replaced after 7 d.
RNA extraction and quantitative real-time RT-PCR. Sorted cells in 500 ml Qiazol (Qiagen) were stored at -80 1C. RNA was extracted with RNeasy RNA isolation kits (Qiagen) and was reverse-transcribed into cDNA with Superscript RT II or Superscript RT III (Invitrogen). SYBRGreen Universal Master Mix and a GeneAmp 7700 sequence detection system (Applied Biosystems) were used for real-time PCR with primers synthesized by Operon, as published, 22 
